Evaluating the efficacy of immunotherapy in gastric cancer: Insights from immune checkpoint inhibitors

被引：0
|
作者：
Yang, Yu-Nuo [1 ]
Wang, Li-Sheng [2 ]
Dang, Yan-Qi [1 ]
Ji, Guang [1 ]
机构：
[1] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Digest Dis, China Canada Ctr Res Digest Dis, 725 South Wanping Rd, Shanghai 200032, Peoples R China
[2] Univ Ottawa, Dept Biochem, Ottawa, ON K1H 8M5, Canada
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2024年 / 30卷 / 32期
关键词：
Gastric cancer; Immune checkpoint inhibitors; Sarcopenia; Myosteatosis; Prediction model;
D O I：
10.3748/wjg.v30.i32.3726
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The emergence of immunotherapy, particularly immune checkpoint inhibitors (ICIs), represents a groundbreaking approach to treating gastric cancer (GC). However, the prognosis of GC patients receiving ICI treatment is influenced by various factors. This manuscript identified sarcopenia and myosteatosis as inde-pendent prognostic factors impacting the outcomes of GC patients treated with ICIs. Additionally, this study introduced a visual predictive model to estimate the prognosis of GC patients. If confirmed by further studies, this observation could provide valuable insights to propel the advancement of personalized clinical medicine and the integration of precision medicine practices.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapy
    Ohnuma, Kei
    Hatano, Ryo
    Dang, Nam H.
    Morimoto, Chikao
    MODERN RHEUMATOLOGY, 2019, 29 (05) : 721 - 732
  • [32] Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer
    Cejuela, Monica
    Vethencourt, Andrea
    Pernas, Sonia
    CURRENT ONCOLOGY REPORTS, 2022, 24 (12) : 1801 - 1819
  • [33] Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors
    Catanzaro, Elena
    Beltran-Visiedo, Manuel
    Galluzzi, Lorenzo
    Krysko, Dmitri V.
    CELLULAR & MOLECULAR IMMUNOLOGY, 2025, 22 (01) : 24 - 39
  • [34] Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer
    Mónica Cejuela
    Andrea Vethencourt
    Sonia Pernas
    Current Oncology Reports, 2022, 24 : 1801 - 1819
  • [35] Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy
    Marquez-Garban, Diana C.
    Deng, Gang
    Comin-Anduix, Begonya
    Garcia, Alejandro J.
    Xing, Yanpeng
    Chen, Hsiao-Wang
    Cheung-Lau, Gardenia
    Hamilton, Nalo
    Jung, Michael E.
    Pietras, Richard J.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019, 193
  • [36] Towards the era of immune checkpoint inhibitors and personalized cancer immunotherapy
    Nakajima, Hiromichi
    Nakatsura, Tetsuya
    IMMUNOLOGICAL MEDICINE, 2021, 44 (01) : 10 - 15
  • [37] The efficacy of immune checkpoint inhibitors in patients with cancer with pseudoprogression
    Lyadova, Marina
    Fedorinov, Denis
    Pardabekova, Olesya
    Nosova, Margarita
    Tuleiko, Veronika
    Lyadov, Vladimir
    Kuzmina, Evgenia
    Antonova, Tatiana
    Lyadov, Konstantin
    Galkin, Vsevolod
    Poddubnaya, Irina
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Efficacy of immune checkpoint inhibitors and age in cancer patients
    Huang, Xuan-zhang
    Gao, Peng
    Song, Yong-xi
    Sun, Jing-xu
    Chen, Xiao-wan
    Zhao, Jun-hua
    Wang, Zhen-ning
    IMMUNOTHERAPY, 2020, 12 (08) : 587 - 603
  • [39] Association of gastric background mucosa status with the efficacy of immune checkpoint inhibitors in patients with unresectable advanced gastric cancer
    Kamijo, Y.
    Nagata, Y.
    Suzuki, H.
    Kunimoto, H.
    Seki, A.
    Sekino, Y.
    Sakon, M.
    Ushimaru, H.
    Hara, E.
    ANNALS OF ONCOLOGY, 2024, 35 : S190 - S190
  • [40] Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients
    Jingjing Zhang
    Lei Wang
    Shasha Zhang
    Ruijie Cao
    Yufei Zhao
    Yue Zhao
    Yanrong Song
    Zhanjun Guo
    BMC Cancer, 24
12345